Discovering Researchers Contributing to New Drug Development in Biotechnology and Medical Science
Grand Prize of 300 Million Won, 50 Million Won Each for Two Young Researcher Awardees
Nominations Accepted from July 1 to August 31

The Im Seong-gi Foundation is accepting nominations for candidates for the 6th Im Seong-gi Researcher Award, which aims to recognize outstanding research achievements in the fields of biotechnology and medical science.


On June 30, the Im Seong-gi Foundation announced that it will be accepting nominations for the 6th Im Seong-gi Researcher Award from July 1 to August 31.


Notice for Nominations for the 5th Seonggi Lim Researcher Award Promotional Material. Seonggi Lim Foundation

Notice for Nominations for the 5th Seonggi Lim Researcher Award Promotional Material. Seonggi Lim Foundation

View original image

The Im Seong-gi Researcher Award was established to carry on the drug development philosophy of the late Im Seong-gi, founder of Hanmi Group. The award is intended for researchers who have produced research results that can be applied to the development of new drugs.


The total prize amount is 400 million won. The grand prize winner will receive 300 million won, while two recipients of the Young Researcher Award will each receive 50 million won.


Eligible candidates are researchers of Korean nationality or of Korean descent who have achieved research results in biotechnology or medical science that can contribute to new drug development. For the main award, eligible papers must have been published within the last five years from the application deadline, while for the Young Researcher Award, papers must have been published within the last three years. The Young Researcher Award is open to researchers under the age of 45.


Candidates may be recommended by the heads of relevant academic societies, associations, research institutions, or universities, or by individuals with expertise in the relevant field. The winners will be selected through a review by the judging committee and approval by the foundation's board of directors, with the results to be announced at the end of the year. The award ceremony is scheduled to be held in March next year.



Changsoo Kim, Chairman of the Im Seong-gi Foundation, stated, "We will continue to support the achievements and passion of researchers, and discover outstanding research results, in line with Chairman Im Seong-gi's philosophy toward new drug development."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing